Sintofarm will give up medicine manufacture to become real estate developer

The medicine producer Sintofarm (SINT) summoned its shareholders at the end of December to decide on selling equipment, trademarks and other shares and on taking over the name Imosint and change the field of activity for real estate development. Shareholders must decide on selling the whole trade fund of the company except for buildings. The meeting will be held on December 21. Sintofarm has a factory in ...

Developed by Codecraftsman